Orbitofrontal morphology in people at high risk of developing schizophreniaEUROPEAN PSYCHIATRYIF6.72020-04-1640PREAI
Assessment of intradimensional/extradimensional attentional set-shifting in ratsNEUROSCIENCE AND BIOBEHAVIORAL REVIEWSIF7.92018-06-0155PREAI
Innovative solutions to novel drug development in mental healthNEUROSCIENCE AND BIOBEHAVIORAL REVIEWSIF7.92013-12-0181OAAI
Measuring the construct of executive control in schizophrenia: Defining and validating translational animal paradigms for discovery researchNEUROSCIENCE AND BIOBEHAVIORAL REVIEWSIF7.92013-11-0157PREAI
Set shifting and reversal learning in borderline personality disorderPERSONALITY AND MENTAL HEALTHIF2.72013-06-037PREAI
GREY MATTER DENSITY AND CORTICAL THICKNESS VARY WITH DIFFERENT ORBITOFRONTAL SULCOGYRAL PATTERNSSCHIZOPHRENIA RESEARCHIF3.52012-04-010PREAI
IMPAIRMENT IN COGNITIVE FLEXIBILITY IN PATIENTS WITH BIPOLAR DISORDER VERSUS PATIENTS WITH SCHIZOPHRENIASCHIZOPHRENIA RESEARCHIF3.52012-04-010PREAI
Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesionsPSYCHOPHARMACOLOGYIF3.32008-10-1755PREAI
Difficulty overcoming learned non-reward during reversal learning in ratswith ibotenic acid lesions of orbital prefrontal cortexLINKING AFFECT TO ACTION: CRITICAL CONTRIBUTIONS OF THE ORBITOFRONTAL CORTEXIF02007-12-1876PREAI
The effect of the adenosine A2A antagonist KW-6002 on motor and motivational processes in the ratPSYCHOPHARMACOLOGYIF3.32005-12-1327PREAI
Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effectsNEUROSCIENCE AND BIOBEHAVIORAL REVIEWSIF7.92005-05-01540PREAI
5-HT6 receptor antagonists improve performance in an attentional set shifting task in ratsPSYCHOPHARMACOLOGYIF3.32005-04-21111PREAI
Cholinergic neurotransmission influences covert orientation of visuospatial attention in the ratPSYCHOPHARMACOLOGYIF3.32000-05-2492PREAI
The worst of both worlds: Poverty and politics in the BalkansENVIRONMENTAL HEALTH PERSPECTIVESIF9.81999-12-018OAAI